Evaluation of the Effect of Genetic Polymorphisms in ERCC1 and OCT2 on the Occurrence and Severity of Cisplatin-induced Nephrotoxicity

NCT05247671 · clinicaltrials.gov ↗

UNKNOWN

Status

89

Enrollment

OTHER

Sponsor class

Conditions

Cisplatin Adverse Reaction

Interventions

GENETIC: ERCC1
GENETIC: OCT2

Sponsor

Ain Shams University